Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma

Sato,Junichiro; Fujiwara,Masachika; Kawakami,Tomohiro; Sumiishi,Ayumi; Sakata,Seiji; Sakamoto,Atsuhiko; Kurata,Atsushi

doi:10.3892/ol.2011.383

Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma

Authors:
- Junichiro Sato
- Masachika Fujiwara
- Tomohiro Kawakami
- Ayumi Sumiishi
- Seiji Sakata
- Atsuhiko Sakamoto
- Atsushi Kurata
View Affiliations

Affiliations: Kyorin University Hospital, Kyorin University School of Medicine, Tokyo, Japan, Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan, Juntendo University Urayasu Hospital, Chiba, Japan, Department of Molecular Pathology, Tokyo Medical University, Tokyo 160-8402, Japan
Published online on: August 17, 2011 https://doi.org/10.3892/ol.2011.383
Pages: 1025-1032

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The majority of thymomas are histologically characterized by tumor-infiltrating lymphocytes. Mature dendritic cells (DCs) are known to assemble lymphocytes through antigen presentation to T lymphocytes. Fascin, a 55-kDa actin-binding protein and a known marker for mature DCs, regulates filaments necessary for the formation of filopodia in cell migration. Moreover, fascin expression in various epithelial neoplasms has recently been reported to be associated with invasion of tumor cells and clinically aggressive manifestations. In the present study, we investigated fascin expression immunohistochemically in tissues of thymomas and thymic carcinomas surgically resected at our institute. A total of 34 thymomas and 5 thymic carcinomas were included. The amount and immunohistochemical intensity of both fascin+ DCs and tumor epithelium were counted and assessed, and the clinicopathological data were also scored. Statistical analyses revealed that the amount of fascin+ DCs with the formation of clusters was associated with lymphocyte-rich variants (p=0.002) and cortical differentiation (p=0.037) of thymoma with complication from myasthenia gravis (p=0.002). The quantity of fascin+ epithelium was associated with a strong intensity of fascin in infiltrating DCs (p=0.002) with the formation of clusters (p=0.002) and favorable prognosis, as assessed by the Masaoka staging system (p=0.001). The amount of infiltrating DCs (p=0.024) and fascin+ epithelium were lower in thymic carcinoma. It was concluded that fascin+ epithelium may induce tumor immunity through the surveillance activity of fascin+ DCs in thymic neoplasms, thus improving prognosis.

View Figures

View References

1	Kurup A and Loehrer PJ Sr: Thymoma and thymic carcinoma: therapeutic approaches. Clin Lung Cancer. 6:28–32. 2004. View Article : Google Scholar : PubMed/NCBI
2	Duwe BV, Sterman DH and Musani AI: Tumors of the mediastinum. Chest. 128:2893–2909. 2005. View Article : Google Scholar : PubMed/NCBI
3	Marx A, Ströbel P, Zettl A, Chan JKC, Müller-Hermelink HK, Harris NL, Kuo TT, Shimosato Y and Engel P: Thymomas. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (WHO classification of tumors series). Travis WD, Brambilla E, Müller-Helmelink HK and Harris CC: IARC Press; Lyon, France: pp. 152–171. 2004
4	Margaritora S, Cesario A, Cusumano G, Meacci E, D’Angelillo R, Bonassi S, Carnassale G, Porziella V, Tessitore A, Vita ML, Lauriola L, Evoli A and Granone P: Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg. 89:245–252. 2010.PubMed/NCBI
5	Masaoka A, Monden Y, Nakahara K and Tanioka T: Follow-up study of thymomas with special reference to their clinical stages. Cancer. 48:2485–2492. 1981. View Article : Google Scholar : PubMed/NCBI
6	Okumura M, Miyoshi S, Takeuchi Y, Yoon HE, Minami M, Takeda SI, Fujii Y, Nakahara K and Matsuda H: Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg. 117:605–613. 1999. View Article : Google Scholar : PubMed/NCBI
7	Gerner MY and Mescher MF: Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells. J Immunol. 182:2726–2737. 2009. View Article : Google Scholar : PubMed/NCBI
8	Kornstein MJ, Hoxie JA, Levinson AI and Brooks JJ: Immunohistology of human thymomas. Arch Pathol Lab Med. 109:460–463. 1985.
9	Pomplun S, Wotherspoon AC, Shah G, Goldstraw P, Ladas G and Nicholson AG: Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms. Histopathology. 40:152–158. 2002. View Article : Google Scholar : PubMed/NCBI
10	Lee D and Wright DH: Immunohistochemical study of 22 cases of thymoma. J Clin Pathol. 41:1297–1304. 1988. View Article : Google Scholar : PubMed/NCBI
11	Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G and Said JW: Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin’s disease. Evidence for a dendritic or B cell derivation? Am J Pathol. 150:543–562. 1997.PubMed/NCBI
12	Kurata A, Terado Y, Schulz A, Fujioka Y and Franke FE: Inflammatory cells in the formation of tumor-related sarcoid reactions. Hum Pathol. 36:546–554. 2005. View Article : Google Scholar : PubMed/NCBI
13	Machesky LM and Li A: Fascin: invasive filopodia promoting metastasis. Commun Integr Biol. 3:263–270. 2010. View Article : Google Scholar : PubMed/NCBI
14	Darnel AD, Behmoaram E, Vollmer RT, Corcos J, Bijian K, Sircar K, Su J, Jiao J, Alaoui-Jamali MA and Bismar TA: Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res. 15:1376–1383. 2009. View Article : Google Scholar : PubMed/NCBI
15	Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y and Tsuneyoshi M: zFascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol. 100:575–579. 2009. View Article : Google Scholar : PubMed/NCBI
16	Yildiz L, Kefeli M, Aydin O and Kandemir B: Fascin expression in melanocytic lesions of the skin. Eur J Dermatol. 19:445–450. 2009.PubMed/NCBI
17	Zhang FR, Tao LH, Shen ZY, Lv Z, Xu LY and Li EM: Fascin expression in human embryonic, fetal, and normal adult tissue. J Histochem Cytochem. 56:193–199. 2008. View Article : Google Scholar : PubMed/NCBI
18	Brunhuber T, Haybaeck J, Schäfer G, Mikuz G, Langhoff E, Saeland S, Lebecque S, Romani N and Obrist P: Immunohistochemical tracking of an immune response in mammary Paget’s disease. Cancer Lett. 272:206–220. 2008.PubMed/NCBI
19	Ozerhan IH, Ersoz N, Onguru O, Ozturk M, Kurt B and Cetiner S: Fascin expression in colorectal carcinomas. Clinics. 65:157–164. 2010. View Article : Google Scholar : PubMed/NCBI
20	Onodera M, Zen Y, Harada K, Sato Y, Ikeda H, Itatsu K, Sato H, Ohta T, Asaka M and Nakanuma Y: Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma. Lab Invest. 89:1261–1274. 2009. View Article : Google Scholar : PubMed/NCBI
21	Xie JJ, Xu LY, Wu JY, Shen ZY, Zhao Q, Du ZP, Lv Z, Gu W, Pan F, Xu XE, Xie D and Li EM: Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol. 176:939–951. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kefeli M, Yildiz L, Kaya FC, Aydin O and Kandemir B: Fascin expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 28:328–333. 2009. View Article : Google Scholar : PubMed/NCBI
23	Durmaz A, Kurt B, Ongoru O, Karahatay S, Gerek M and Yalcin S: Significance of fascin expression in laryngeal squamous cell carcinoma. J Laryngol Otol. 124:194–198. 2010. View Article : Google Scholar : PubMed/NCBI
24	Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran C, Zakowski MF and Suster S: Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer. 112:2780–2788. 2008. View Article : Google Scholar
25	Kondo K, Mukai K, Sato Y, Matsuno Y, Shimosato Y and Monden Y: An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes. Am J Surg Pathol. 14:1139–1147. 1990. View Article : Google Scholar
26	Rouse RV and Weiss LM: Human thymomas: evidence of immunohistologically defined normal and abnormal microenvironmental differentiation. Cell Immunol. 111:94–106. 1988. View Article : Google Scholar
27	Kurata A, Terado Y, Izumi M, Fujioka Y and Franke FE: Where does the antigen of cutaneous sarcoidosis come from? J Cutan Pathol. 37:211–221. 2010. View Article : Google Scholar : PubMed/NCBI
28	Wakimoto T, Tomisaka R, Nishikawa Y, Sato H, Yoshino T and Takahashi K: Identification and characterization of human thymic cortical dendritic macrophages that may act as professional scavengers of apoptotic thymocytes. Immunobiology. 213:837–847. 2008. View Article : Google Scholar : PubMed/NCBI
29	Ambe K, Mori M and Enjoji M: S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer. 63:496–503. 1989. View Article : Google Scholar : PubMed/NCBI
30	Becker Y: Anticancer role of dendritic cells (DC) in human and experimental cancers – a review. Anticancer Res. 12:511–520. 1992.
31	Müller-Hermelink HK, Möller P, Engel P, Menestrina F, Kuo TT, Shimosato Y, Ströbel PH, Asamura H, Marx A, Masaoka A, Harris NL and Sobin LH: Tumours of the thymus. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (WHO classification of tumors series). Travis WD, Brambilla E, Müller-Helmelink HK and Harris CC: IARC Press; Lyon, France: pp. 145–151. 2004
32	Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze’ev A and Robine S: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 67:6844–6853. 2007. View Article : Google Scholar : PubMed/NCBI